Old Web
English
Sign In
Acemap
>
authorDetail
>
Guus van Dongen
Guus van Dongen
Weizmann Institute of Science
Medicine
Biodistribution
Nuclear medicine
Materials science
90Y ibritumomab tiuxetan
5
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Optimizing iterative reconstruction settings for 89 Zr-immuno-PET to improve image quality
2018
Keiichi Magota
Yvonne W. S. Jauw
Dennis F. R. Heijtel
Josée M. Zijlstra
Guus van Dongen
Adriaan Lammertsma
R. Boellaard
Marc C. Huisman
Show All
Source
Cite
Save
Citations (0)
Biodistribution and radiation dosimetry of 90Y-ibritumomab-tiuxetan using 89Zr-ibritumomab-tiuxetan and PET in patients with relapsed B-cell non-Hodgkin's lymphoma
2010
S. Nafees Rizvi
O.J. Visser
Guus van Dongen
Otto Hoekstra
Josée M. Zijlstra
Peter C. Huijgens
Mark Lubberink
Show All
Source
Cite
Save
Citations (0)
Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with PET
2006
Lars R. Perk
O.J. Visser
Gerard W. M. Visser
Josée M. Zijlstra
Guus van Dongen
Show All
Source
Cite
Save
Citations (0)
Targeted Radiotherapy of Squamous Head and Neck Cancer
2000
Guus van Dongen
Frank B. van Gog
Ruud Brakenhoff
Jasper J. Quak
Remco de Bree
Gerard W. M. Visser
G. B. Snow
Show All
Source
Cite
Save
Citations (0)
The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells
2000
Journal of Biological Chemistry
Rinat Eshel
Alexandra Zanin
Orit Sagi-Assif
Tzipi Meshel
Nechama I. Smorodinsky
Oren Dwir
Ronen Alon
Ruud Brakenhoff
Guus van Dongen
Isaac P. Witz
Show All
Source
Cite
Save
Citations (34)
1